[{"NetIncomeLoss_1_Q1_USD":5793000.0,"MarketableSecuritiesCurrent_0_Q1_USD":26452000.0,"DepreciationAndAmortization_1_Q1_USD":2761000.0,"IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses_1_Q1_USD":1900000.0,"CommitmentsAndContingencies_0_Q1_USD":null,"GainLossOnSaleOfPropertyPlantEquipment_1_Q1_USD":null,"LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_0_Q1_USD":21374000.0,"InventoryFinishedGoodsNetOfReserves_0_Q1_USD":37310000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":-6027000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-92503000.0,"CertificatesOfDepositAtCarryingValue_0_Q1_USD":1300000.0,"AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q1_USD":141000.0,"GoodwillImpairmentLoss_1_Q1_USD":18144000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1_Q1_USD":-129000.0,"InterestIncomeExpenseNonoperatingNet_1_Q1_USD":279000.0,"ProvisionForDoubtfulAccounts_1_Q1_USD":-15000.0,"GoodwillForeignCurrencyTranslationGainLoss_1_Q1_USD":-148000.0,"AssetsCurrent_0_Q1_USD":161126000.0,"SellingGeneralAndAdministrativeExpense_1_Q1_USD":14431000.0,"FinanceLeaseLiabilityNoncurrent_0_Q1_USD":468000.0,"ContractWithCustomerLiability_0_Q1_USD":100000.0,"CostOfGoodsAndServicesSold_1_Q1_USD":14200000.0,"FinanceLeaseLiabilityPaymentsDueYearTwo_0_Q1_USD":174000.0,"FinanceLeaseInterestExpense_1_Q1_USD":7000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q1_USD":null,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q1_USD":2304000.0,"FinanceLeaseLiabilityUndiscountedExcessAmount_0_Q1_USD":66000.0,"NumberOfReportingUnits_1_Q1_pure":2.0,"FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q1_USD":204000.0,"CommonStockSharesIssued_0_Q1_shares":14198000.0,"InventoryWorkInProcessNetOfReserves_0_Q1_USD":13997000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q1_USD":2240000.0,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"ProductWarrantyAccrual_0_Q1_USD":0.0,"GainLossOnInvestments_1_Q1_USD":null,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q1_USD":1793000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":6050000.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q1_USD":14944000.0,"EarningsPerShareBasic_1_Q1_USD":0.41,"InventoryWriteDown_1_Q1_USD":831000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":14353000.0,"IncreaseDecreaseInAccruedLiabilities_1_Q1_USD":-3233000.0,"AccountsReceivableNetCurrent_0_Q1_USD":28101000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_1_Q1_pure":null,"IncomeTaxExpenseBenefit_1_Q1_USD":1580000.0,"CommonStockValue_0_Q1_USD":142000.0,"EffectOfExchangeRateOnCashAndCashEquivalents_1_Q1_USD":-31000.0,"IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_1_Q1_USD":400000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFive_0_Q1_USD":2059000.0,"CashAndCashEquivalentsPeriodIncreaseDecrease_1_Q1_USD":-91630000.0,"IntangibleAssetsGrossExcludingGoodwill_0_Q1_USD":118859000.0,"EffectiveIncomeTaxRateContinuingOperations_1_Q1_pure":0.214,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":48360000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":21731000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":65833000.0,"OtherAssetsNoncurrent_0_Q1_USD":27507000.0,"AmortizationOfIntangibleAssets_1_Q1_USD":1300000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":421000.0,"Assets_0_Q1_USD":398913000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":5664000.0,"IncreaseDecreaseInInventories_1_Q1_USD":3632000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_1_Q1_USD":14990000.0,"CostsAndExpenses_1_Q1_USD":28303000.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_1_Q1_USD":-24522000.0,"FinanceLeaseLiabilityPaymentsDueYearFive_0_Q1_USD":44000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":-141000.0,"AccruedLiabilitiesAndOtherLiabilities_0_Q1_USD":16282000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q1_USD":-129000.0,"ShareBasedCompensation_1_Q1_USD":-207000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":23528000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":-2004000.0,"AssetImpairmentCharges_1_Q1_USD":0.0,"CommonStockSharesOutstanding_0_Q1_shares":14198000.0,"EarningsPerShareDiluted_1_Q1_USD":0.4,"PaymentsToAcquireMarketableSecurities_1_Q1_USD":13787000.0,"FinanceLeaseWeightedAverageDiscountRatePercent_0_Q1_pure":0.051,"Goodwill_0_Q1_USD":33802000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q1_USD":7373000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q1_USD":141000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":1045000.0,"InventoryRawMaterialsNetOfReserves_0_Q1_USD":10846000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":14202000.0,"BusinessCombinationContingentConsiderationLiabilityCurrent_0_Q1_USD":4303000.0,"LiabilitiesCurrent_0_Q1_USD":26188000.0,"AccountsPayableCurrent_0_Q1_USD":9906000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":5659000.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":null,"PropertyPlantAndEquipmentNet_0_Q1_USD":54232000.0,"BusinessCombinationContingentConsiderationLiabilityNoncurrent_0_Q1_USD":40251000.0,"InventoryNoncurrent_0_Q1_USD":27072000.0,"CapitalExpendituresIncurredButNotYetPaid_1_Q1_USD":55000.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"DeferredIncomeTaxLiabilitiesNet_0_Q1_USD":16030000.0,"LeaseCost_1_Q1_USD":681000.0,"ShortTermLeaseCost_1_Q1_USD":null,"WeightedAverageNumberDilutedSharesOutstandingAdjustment_1_Q1_shares":151000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q1_pure":0.041,"FinanceLeaseRightOfUseAssetAmortization_1_Q1_USD":37000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q1_USD":98718000.0,"FinanceLeaseLiabilityPaymentsDueYearThree_0_Q1_USD":166000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":1141000.0,"FinanceLeaseLiabilityPaymentsDueYearFour_0_Q1_USD":160000.0,"AccruedProfessionalFeesCurrent_0_Q1_USD":4908000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":251219000.0,"AllowanceForDoubtfulAccountsReceivableCurrent_0_Q1_USD":935000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.01,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.01,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q1_USD":8681000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q1_USD":2123000.0,"PaymentsToAcquireBusinessesNetOfCashAcquired_1_Q1_USD":92983000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":445000.0,"CommonStockSharesAuthorized_0_Q1_shares":90000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":35397000.0,"OperatingIncomeLoss_1_Q1_USD":7094000.0,"IncreaseDecreaseInAccruedIncomeTaxesPayable_1_Q1_USD":166000.0,"InventoryNet_0_Q1_USD":35081000.0,"StockRepurchasedDuringPeriodValue_1_Q1_USD":null,"FinanceLeaseLiabilityPaymentsDueAfterYearFive_0_Q1_USD":null,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1_Q1_pure":0.0,"PreferredStockValue_0_Q1_USD":0.0,"DeferredIncomeTaxExpenseBenefit_1_Q1_USD":550000.0,"OperatingLeaseCost_1_Q1_USD":574000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":723000.0,"StockholdersEquity_0_Q1_USD":293694000.0,"GoodwillAcquiredDuringPeriod_1_Q1_USD":44400000.0,"FinanceLeaseLiabilityCurrent_0_Q1_USD":214000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":1019000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1_Q1_USD":544000.0,"VariableLeaseCost_1_Q1_USD":63000.0,"RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_1_Q1_USD":51000.0,"ImpairmentOfIntangibleAssetsFinitelived_1_Q1_USD":318000.0,"DeferredTaxAssetsValuationAllowance_0_Q1_USD":0.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":-207000.0,"PreferredStockSharesAuthorized_0_Q1_shares":1250000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":2707000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":398913000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":1481000.0,"StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures_1_Q1_USD":null,"Ticker":"ANIK","CIK":"898437","name":"ANIKA THERAPEUTICS, INC.","OfficialName":"Anika Therapeutics Inc. Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"337949354.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Electromedical & Electrotherapeutic Apparatus","Market":"NASDAQ","SP500":"nan","filed":"20200522"}]